Table 1 Baseline patient characteristics and suPAR serum concentrations
Parameter | All patients | Sepsis | Non-sepsis |
|---|---|---|---|
Number | 273 | 197 | 76 |
Sex (male/female) | 172/101 | 128/69 | 44/32 |
Age median (range) (years) | 64 (18 to 90) | 65 (20 to 90) | 60 (18 to 85) |
APACHE-II score median (range) | 17 (0 to 40) | 18 (0 to 40) | 15 (0 to 31) |
SOFA score median (range) | 11 (0 to 17) | 11 (2 to 17) | 7 (0 to 16) |
SAPS2 score median (range) | 44 (0 to 80) | 44.5 (0 to 79) | 41.5 (13 to 80) |
ICU days median (range) | 9 (0 to 137) | 12 ** (0 to 137) | 6 ** (1 to 45) |
Hospital days median (range) | 27 (2 to 151) | 30 ** (2 to 151) | 14 ** (2 to 85) |
Death during ICU n (%) | 75 (32.8%) | 60 (35.9%) | 15 (24.2%) |
Death during follow-up n (%) | 111 (51.9%) | 83 (53.5%) | 28 (47.5%) |
Mechanical ventilation n (%) | 194 (73.2%) | 144 (75%) | 50 (68.5%) |
Ventilation time median (range) (h) | 126 (0 to 2,966) | 180 * (0 to 2,966) | 48.5 * (0 to 986) |
pre-existing diabetes n (%) | 87 (32.7%) | 59 (30.7%) | 28 (37.8%) |
BMI median (range) (m2/kg) | 25.8 (14.0 to 66.7) | 25.9 (14.0 to 66.7) | 25.8 (15.9 to 53.3) |
suPAR Day 1 median (range) (ng/mL) | 9.80 (0 to 20) | 11.05 ** (1.87 to 20) | 7.62 ** (0 to 20) |
suPAR Day 3 median (range) (ng/mL) | 10.83 (2.33 to 20) | 12.11 * (2.59 to 20) | 8.47 * (2.33 to 20) |
suPAR Day 7 median (range) (ng/mL) | 11.90 (3.67 to 20) | 12.27 (3.94 to 20) | 9.73 (3.67 to 20) |